SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-07-076176
Filing Date
2007-10-23
Accepted
2007-10-22 17:31:23
Documents
13

Document Format Files

Seq Description Document Type Size
1 425 a07-27173_4425.htm 425 22407
2 GRAPHIC g271734moi001.jpg GRAPHIC 30237
3 GRAPHIC g271734moi002.jpg GRAPHIC 116940
4 GRAPHIC g271734moi003.jpg GRAPHIC 50476
5 GRAPHIC g271734moi004.jpg GRAPHIC 71986
6 GRAPHIC g271734moi005.jpg GRAPHIC 65571
7 GRAPHIC g271734moi006.jpg GRAPHIC 71223
8 GRAPHIC g271734moi007.jpg GRAPHIC 65153
9 GRAPHIC g271734moi008.jpg GRAPHIC 55659
10 GRAPHIC g271734moi009.jpg GRAPHIC 68550
11 GRAPHIC g271734moi010.jpg GRAPHIC 55551
12 GRAPHIC g271734moi011.jpg GRAPHIC 54236
13 GRAPHIC g271734moi012.jpg GRAPHIC 22665
  Complete submission text file 0001104659-07-076176.txt   1029661
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filed by) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-15006 | Film No.: 071183833
SIC: 2835 In Vitro & In Vivo Diagnostic Substances